Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01971684 · ClinicalTrials.gov registry record
ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 120
- Enrollment target
NCT01971684: Completed study, sponsored by Boston Children's Hospital.
NCT01971684 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01971684 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
The purpose of this study is to understand physician treatment decisions in selecting specific second line treatments in pediatric ITP and to determine the effectiveness of different second line ITP treatments. Eligible patients are those ages 1-18 years who are starting on a new second line treatment for ITP, defined as any treatment other than IVIG, steroids, anti-D globulin, or aminocaproic acid. Enrolled patients remain on the study for approximately one year.
Primary Outcome
Kids ITP Tool, Memorial Symptom Assessment Scale, Fatigue Scale
Interventions
- DRUG Second Line ITP agents
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2013-08 |
| Est. Completion | 2017-04 |
What the finished NCT01971684 record still lists
NCT01971684 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Second Line ITP agents is the first listed.
NCT01971684 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01971684 about?
NCT01971684 is a clinical study titled "ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP". The purpose of this study is to understand physician treatment decisions in selecting specific second line treatments in pediatric ITP and to determine the effectiveness of different second line ITP treatments. Eligible patients are those ages 1-18 years who are starting on a new second line treatme...
What is the current status of trial NCT01971684?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2013-08. Estimated completion is 2017-04.
What interventions are being tested in trial NCT01971684?
The interventions under investigation include: Second Line ITP agents (DRUG).
Who is sponsoring clinical trial NCT01971684?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia